CNPAX
Price
$72.71
Change
+$0.65 (+0.90%)
Updated
Jul 31 closing price
Net Assets
170.23B
PGIIX
Price
$20.97
Change
+$0.27 (+1.30%)
Updated
Jul 31 closing price
Net Assets
111.34M
Interact to see
Advertisement

CNPAX vs PGIIX

CNPAX vs PGIIX Comparison Chart in %
View a ticker or compare two or three
VS
CNPAX vs. PGIIX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNPAX is a Buy and PGIIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CNPAX has more cash in the bank: 170B vs. PGIIX (111M). CNPAX pays higher dividends than PGIIX: CNPAX (0.97) vs PGIIX (0.00). CNPAX was incepted earlier than PGIIX: CNPAX (24 years) vs PGIIX (12 years). PGIIX (1.01) is less costly to investors than CNPAX (0.74). PGIIX is a more actively managed with annual turnover of: 32.00 vs. CNPAX (23.00). CNPAX has a lower initial minimum investment than PGIIX: CNPAX (250) vs PGIIX (100000). CNPAX annual gain was more profitable for investors over the last year : 6.66 vs. PGIIX (-23.61). CNPAX return over 5 years is better than : 12.85 vs. PGIIX (-23.88).
CNPAXPGIIXCNPAX / PGIIX
Total Expense Ratio0.741.0173%
Annual Report Gross Expense Ratio0.741.0173%
Fund Existence24 years12 years-
Gain YTD4.921-5.668-87%
Front Load4%N/A-
Min. Initial Investment2501000000%
Min. Initial Investment IRAN/AN/A-
Net Assets170B111M153,153%
Annual Yield % from dividends0.970.00-
Returns for 1 year6.66-23.61-28%
Returns for 3 years33.46-10.00-335%
Returns for 5 years12.85-23.88-54%
Returns for 10 years113.2589.60126%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LDMOX21.990.81
+3.82%
Lazard Developing Markets Equity Open
OIEIX27.930.22
+0.79%
JPMorgan Equity Income A
GTLOX23.840.06
+0.25%
Glenmede Disciplined US Eq Ptf
HFYYX15.98N/A
N/A
Hartford Schroders Intl Multi-Cp Val Y
GTMUX24.78-0.03
-0.12%
Goldman Sachs Small/Mid Cap Growth R6